Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 02, 2018 16:01 ET | Source: OpGen, Inc.

OpGen Reports Second Quarter 2018 Financial Results And Provides Business Update

Revenue increases 12% to $0.8 million, net loss narrows 21% to $3.3 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., Aug. 02, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc....
July 25, 2018 08:30 ET | Source: OpGen, Inc.

OpGen Announces Date of Second Quarter 2018 Financial Results Conference Call

GAITHERSBERG, Md., July 25, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that the Company will report financial results for the three and six months ended June 30, 2018 after...
June 14, 2018 08:30 ET | Source: OpGen, Inc.

OpGen Modifies Terms of Debt with Merck Global Health Innovation Fund

GAITHERSBERG, Md., June 14, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has negotiated modifications related to its $1,000,000 Second Amended and Restated Senior...
June 12, 2018 08:30 ET | Source: OpGen, Inc.

OpGen Presents Data at ASM Microbe 2018 Demonstrating High Accuracy of Acuitas® for Predicting Antibiotic Resistance in Urine Specimens

90% accuracy data presented for rapid antibiotic resistance prediction using Acuitas AMR Gene Panel and Acuitas Lighthouse on urine clinical specimens Prospective clinical trial in Colombia...
June 05, 2018 08:30 ET | Source: OpGen, Inc.

OpGen’s Acuitas® AMR Gene Panel u5.47 Data to be Presented at ASM Microbe 2018

GAITHERSBURG, Md., June 05, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that data on its Acuitas® AMR Gene Panel u5.47 (RUO) and Acuitas Lighthouse® Knowledgebase will be...
May 08, 2018 16:05 ET | Source: OpGen, Inc.

OpGen Reports First Quarter 2018 Financial Results and Provides a Business Update

Revenue increases 10% to $0.8 million, net loss decreases 39% to $3.0 million Conference call begins at 4:30 p.m. Eastern time today GAITHERSBURG, Md., May 08, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc....
May 01, 2018 16:30 ET | Source: OpGen, Inc.

OpGen Announces Date of First Quarter 2018 Financial Results Conference Call

GAITHERSBURG, Md., May 01, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) announced today that the Company will report financial results for the three months ended March 31, 2018 after close of...
April 24, 2018 10:07 ET | Source: OpGen, Inc.

OpGen Highlights Acuitas® Analytical Validation Data for Rapidly Predicting Antibiotic Resistance Using Drug Resistance Gene Profiles at ECCMID

GAITHERSBURG, Md., April 24, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) today announced that it has presented analytical validation results for the Acuitas® AMR Gene Panel u5.47 (RUO) for...
April 19, 2018 09:25 ET | Source: OpGen, Inc.

OpGen Completes Rapid Testing Clinical Trial in Colombia and Expands International Operations

GAITHERSBURG, Md., April 19, 2018 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN) OpGen announced today that it successfully completed a prospective clinical trial evaluating the impact of using rapid...
March 15, 2018 16:05 ET | Source: OpGen, Inc.

OpGen Reports Fourth Quarter and Full Year 2017 Financial Results and Provides a Business Update

Acuitas® AMR Gene Panel u5.47 introduced for Research Use Only Fourth quarter revenue consistent with previous year; net loss decreases 38% year over year Conference call begins at 4:30 p.m. Eastern...